Literature DB >> 15131151

Prevalence and characterization of a binary toxin (actin-specific ADP-ribosyltransferase) from Clostridium difficile.

Carina Gonçalves1, Dominique Decré, Frédéric Barbut, Béatrice Burghoffer, Jean-Claude Petit.   

Abstract

In addition to the two large clostridial cytotoxins (TcdA and TcdB), some strains of Clostridium difficile also produce an actin-specific ADP-ribosyltransferase, called binary toxin CDT. We used a PCR method and Southern blotting for the detection of genes encoding the enzymatic (CDTa) and binding (CDTb) components of the binary toxin in 369 strains isolated from patients with suspected C. difficile-associated diarrhea or colitis. Twenty-two strains (a prevalence of 6%) harbored both genes. When binary toxin production was assessed by Western blotting, 19 of the 22 strains reacted with antisera against the iota toxin of C. perfringens (anti-Ia and anti-Ib). Additionally, binary toxin activity, detected by the ADP-ribosyltransferase assay, was present in only 17 of the 22 strains. Subsequently, all 22 binary toxin-positive strains were tested for the production of toxins TcdA and TcdB, toxinotyped, and characterized by serogrouping, PCR ribotyping, arbitrarily primed PCR, and pulsed-field gel electrophoresis. All binary toxin-positive strains also produced TcdB and/or TcdA. However, they had significant changes in the tcdA and tcdB genes and belonged to variant toxinotypes III, IV, V, VII, IX, and XIII. We could differentiate 16 profiles by using typing methods, indicating that most of the binary toxin-positive strains were unrelated.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15131151      PMCID: PMC404597          DOI: 10.1128/JCM.42.5.1933-1939.2004

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  45 in total

1.  Prevalence and genetic characterization of toxin A variant strains of Clostridium difficile among adults and children with diarrhea in France.

Authors:  Frédéric Barbut; Valérie Lalande; Béatrice Burghoffer; Huong Vu Thien; Emmanuel Grimprel; Jean-Claude Petit
Journal:  J Clin Microbiol       Date:  2002-06       Impact factor: 5.948

2.  Characterization of the enzymatic component of the ADP-ribosyltransferase toxin CDTa from Clostridium difficile.

Authors:  I Gülke; G Pfeifer; J Liese; M Fritz; F Hofmann; K Aktories; H Barth
Journal:  Infect Immun       Date:  2001-10       Impact factor: 3.441

Review 3.  Clostridium difficile colitis.

Authors:  C P Kelly; C Pothoulakis; J T LaMont
Journal:  N Engl J Med       Date:  1994-01-27       Impact factor: 91.245

4.  Characterization of polymorphisms in the toxin A and B genes of Clostridium difficile.

Authors:  M Rupnik; V Braun; F Soehn; M Janc; M Hofstetter; R Laufenberg-Feldmann; C von Eichel-Streiber
Journal:  FEMS Microbiol Lett       Date:  1997-03-15       Impact factor: 2.742

5.  Biochemical characterization and biologic actions of two toxins (D-1 and D-2) from Clostridium difficile.

Authors:  Y Banno; T Kobayashi; H Kono; K Watanabe; K Ueno; Y Nozawa
Journal:  Rev Infect Dis       Date:  1984 Mar-Apr

6.  Molecular analysis of the pathogenicity locus and polymorphism in the putative negative regulator of toxin production (TcdC) among Clostridium difficile clinical isolates.

Authors:  Patrizia Spigaglia; Paola Mastrantonio
Journal:  J Clin Microbiol       Date:  2002-09       Impact factor: 5.948

7.  Use of an enzyme-linked immunoassay for Clostridium difficile serogrouping.

Authors:  M Delmée; C Depitre; G Corthier; A Ahoyo; V Avesani
Journal:  J Clin Microbiol       Date:  1993-09       Impact factor: 5.948

8.  Use of the polymerase chain reaction for the specific and direct detection of Clostridium difficile in human feces.

Authors:  P H Gumerlock; Y J Tang; F J Meyers; J Silva
Journal:  Rev Infect Dis       Date:  1991 Nov-Dec

9.  The enterotoxin from Clostridium difficile (ToxA) monoglucosylates the Rho proteins.

Authors:  I Just; M Wilm; J Selzer; G Rex; C von Eichel-Streiber; M Mann; K Aktories
Journal:  J Biol Chem       Date:  1995-06-09       Impact factor: 5.157

10.  A novel toxinotyping scheme and correlation of toxinotypes with serogroups of Clostridium difficile isolates.

Authors:  M Rupnik; V Avesani; M Janc; C von Eichel-Streiber; M Delmée
Journal:  J Clin Microbiol       Date:  1998-08       Impact factor: 5.948

View more
  50 in total

1.  Molecular analysis of Clostridium difficile PCR ribotype 027 isolates from Eastern and Western Canada.

Authors:  Duncan R MacCannell; Thomas J Louie; Dan B Gregson; Michel Laverdiere; Annie-Claude Labbe; Felicia Laing; Scott Henwick
Journal:  J Clin Microbiol       Date:  2006-06       Impact factor: 5.948

Review 2.  Immune-based treatment and prevention of Clostridium difficile infection.

Authors:  Song Zhao; Chandrabali Ghose-Paul; Keshan Zhang; Saul Tzipori; Xingmin Sun
Journal:  Hum Vaccin Immunother       Date:  2014       Impact factor: 3.452

3.  Genotypic investigation of Clostridium difficile in Prince Edward Island.

Authors:  H Martin; L P Abbott; D E Low; B Willey; M Mulvey; J Scott Weese
Journal:  Can J Infect Dis Med Microbiol       Date:  2008-11       Impact factor: 2.471

Review 4.  Vaccines against Clostridium difficile.

Authors:  Rosanna Leuzzi; Roberto Adamo; Maria Scarselli
Journal:  Hum Vaccin Immunother       Date:  2014-03-17       Impact factor: 3.452

5.  Isolation and characterization of a new Clostridium difficile ribotype during a prospective study in a hospital in Italy.

Authors:  Francesca Sisto; Anna Maraschini; Giovanna Fabio; Serena Serafino; Miriam Zago; Maria Maddalena Scaltrito; Silvana Castaldi
Journal:  Curr Microbiol       Date:  2014-09-21       Impact factor: 2.188

Review 6.  Clostridium difficile infection: molecular pathogenesis and novel therapeutics.

Authors:  Ardeshir Rineh; Michael J Kelso; Fatma Vatansever; George P Tegos; Michael R Hamblin
Journal:  Expert Rev Anti Infect Ther       Date:  2014-01       Impact factor: 5.091

7.  Variations in TcdB activity and the hypervirulence of emerging strains of Clostridium difficile.

Authors:  Jordi M Lanis; Soumitra Barua; Jimmy D Ballard
Journal:  PLoS Pathog       Date:  2010-08-19       Impact factor: 6.823

8.  Truncation in the tcdC region of the Clostridium difficile PathLoc of clinical isolates does not predict increased biological activity of Toxin B or Toxin A.

Authors:  Ruth Murray; Dave Boyd; Paul N Levett; Michael R Mulvey; Michelle J Alfa
Journal:  BMC Infect Dis       Date:  2009-06-28       Impact factor: 3.090

9.  Clostridium difficile toxin CDT induces formation of microtubule-based protrusions and increases adherence of bacteria.

Authors:  Carsten Schwan; Bärbel Stecher; Tina Tzivelekidis; Marco van Ham; Manfred Rohde; Wolf-Dietrich Hardt; Jürgen Wehland; Klaus Aktories
Journal:  PLoS Pathog       Date:  2009-10-16       Impact factor: 6.823

10.  Comparative genome and phenotypic analysis of Clostridium difficile 027 strains provides insight into the evolution of a hypervirulent bacterium.

Authors:  Richard A Stabler; Miao He; Lisa Dawson; Melissa Martin; Esmeralda Valiente; Craig Corton; Trevor D Lawley; Mohammed Sebaihia; Michael A Quail; Graham Rose; Dale N Gerding; Maryse Gibert; Michel R Popoff; Julian Parkhill; Gordon Dougan; Brendan W Wren
Journal:  Genome Biol       Date:  2009-09-25       Impact factor: 13.583

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.